Seattle Genetics Reports Data From Dacetuzumab Phase Ib Combination Clinical Trial...
Seattle Genetics, Inc. (Nasdaq:SGEN) reported data from two phase Ib clinical trials of dacetuzumab, one in combination with Rituxan® (rituximab) and Gemzar® (gemcitabine) for diffuse large...
Medical News Today,
Thu Dec 10 05:27:51 PST 2009
• Found on Yahoo! News
Seattle Genetics to Present at 2009 Deutsche Bank Biotech Confab
BOTHELL, Wash.----Seattle Genetics, Inc. announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present at the 2009 DB-Biotech Boston Confab on Tuesday, De...
Business Wire via Yahoo! Finance,
Thu Dec 10 06:00:00 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
CIDR utilizes Isilon scale-out NAS for genotyping and statistical genetics service...
Isilon Systems today announced that the Center for Inherited Disease Research (CIDR) at Johns Hopkins University is using Isilon scale-out NAS to power its leading-edge genotyping and stati...
News-Medical-Net,
Wed Dec 09 04:46:33 PST 2009
• Found on Yahoo! News
DeCODE Genetics, Inc. - Financial And Strategic Analysis Review - New Report Publi...
The "deCODE genetics, Inc. - Financial and Strategic Analysis Review" is an in-depth business, strategic and financial analysis of deCODE genetics, Inc. The report provides a comprehensive ...
OfficialWire,
Wed Dec 09 06:41:42 PST 2009
• Found on Yahoo! News
New License Agreement with University of Colorado Gives Viral Genetics, Inc., Righ...
SAN MARINO, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Biotechnology company Viral Genetics (Pink Sheets: VRAL) has entered into an exclusive license agreement with the University of Colorado...
redOrbit,
Tue Dec 08 13:09:31 PST 2009
• Found on Yahoo! News
Use of Genetics in the Clinical Evaluation of Cardiomyopathy [Grand Rounds]
Inherited forms of cardiomyopathy are frequently responsible for heart failure that is otherwise unexplained. Evaluation of familial cardiomyopathy should include not only the individual pa...
Journal of the American Medical Association,
Tue Dec 08 13:37:06 PST 2009
• Found on Yahoo! News
Seattle Genetics' Dacetuzumab Drug 'Well Tolerated' in Trial
Seattle Genetics reported the drug dacetuzumab was "well tolerated" when combined with other traeatments for diffuse large B-cell lymphoma and multiple myeloma.
Fox News,
Mon Dec 07 17:05:12 PST 2009
• Found on Yahoo! News
New License Agreement with University of Colorado Gives Viral Genetics, Inc., Righ...
Biotechnology company Viral Genetics has entered into an exclusive license agreement with the University of Colorado to develop cancer therapies based on the work of M. Karen Newell, Ph. D....
PR Newswire via Yahoo! Finance,
Tue Dec 08 10:07:00 PST 2009
• Found on Yahoo! News
Seed Genetics appoints ex-Elders exec
Seed breeder Seed Genetics Australia Ltd has appointed former Elders Ltd executive Mathew Denton as chairman.
Brisbane Times,
Mon Dec 07 16:03:49 PST 2009
• Found on Yahoo! News
More Than Fish Bait: Worms Unlock Secrets To New Epilepsy Treatments
Research in the journal Genetics identifies potential drug development target for epilepsy seizuresA team of scientists from The University of Alabama used worms to reel in information that...
redOrbit,
Wed Dec 09 20:10:18 PST 2009
• Found on Yahoo! News
New York Clears Interleukin Genetics' Dental Test
NEW YORK (GenomeWeb News)
GenomeWeb News,
Mon Dec 07 07:31:02 PST 2009
• Found on Yahoo! News
Seattle Genetics Reports Data from Dacetuzumab Phase Ib Combination Clinical Trial...
SEATTLE----Seattle Genetics, Inc. today reported data from two phase Ib clinical trials of dacetuzumab, one in combination with Rituxan® and Gemzar® for diffuse large B-cell lymphoma , and ...
Business Wire via Yahoo! Finance,
Mon Dec 07 13:05:00 PST 2009
• Found on Yahoo! News
Interleukin Genetics' PST genetic test approved for marketing in New York
Interleukin Genetics, Inc. announced today it has received approval by the State of New York's Department of Health for the Company to sell in New York its PST Genetic Test that determines ...
News-Medical-Net,
Mon Dec 07 05:30:10 PST 2009
• Found on Yahoo! News
Encouraging data from Seattle Genetics' phase I trial of brentuximab vedotin
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and par...
News-Medical-Net,
Mon Dec 07 05:15:23 PST 2009
• Found on Yahoo! News
SemBioSys receives $400,000 milestone payment from AVAC
SemBioSys Genetics Inc. , specializing in the manufacture of high-value proteins and oils in plant seeds, today announced that it has received a $400,000 milestone payment from AVAC Ltd. as...
CNW Group via Yahoo! Finance,
Thu Dec 10 04:00:00 PST 2009
• Found on Yahoo! News
More than fish bait: Worms unlock secrets to new epilepsy treatments
( Genetics Society of America ) Scientists from the University of Alabama used worms to reel in information they hope will lead to a greater understanding of cellular mechanisms that may be...
EurekAlert!,
Wed Dec 09 10:29:38 PST 2009
• Found on Yahoo! News
Ambry Genetics And SoftGenetics Form Exclusive Alliance For Extended Bioinformatic...
Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics' NextGENe software for next-generation se...
BioresearchOnline,
Sun Dec 06 22:41:44 PST 2009
• Found on Yahoo! News
'Genome sequencing can be applied in clinical setting'
The man behind India's genome sequencing spoke to TOI on how the project was a participative venture and what implications it has for future research in medicine, biology and genetics.
The Times of India,
Wed Dec 09 13:59:29 PST 2009
• Found on Yahoo! News
In Comments to GINA Rule, GPPC Tries to Clarify Debate Around 'Underwriting' for W...
Amid ongoing debate that the definition of "underwriting" in the Genetic Information Non-discrimination Act is too broad and might jeopardize enrollment in disease management programs, John...
GenomeWeb News,
Wed Dec 09 12:30:58 PST 2009
• Found on Yahoo! News